logo
Indian Apple reseller Ample to grow revenue by a third as it expands presence, portfolio, CEO says

Indian Apple reseller Ample to grow revenue by a third as it expands presence, portfolio, CEO says

Time of India7 days ago
Indian
Apple reseller
Ample is banking on store expansion and adding more brands and clients to achieve 35% revenue growth in fiscal year 2026, its chief executive said.
The Bengaluru-based firm, which supplies tech products such as
Apple
computers to over 1,500 clients including SAP, Broadcom,
Infosys
, and
Wipro
, operates more than 120 stores across India.
Nearly 50 of these sell Apple products, while others showcase brands like Under Armour and ASICS.
The firm plans to expand its footprint to approximately 175 stores across brands within three years, Ample founder and CEO Rajesh Narang said on Monday, though he declined to specify a target for Apple-only stores.
Ample's revenue stood at 17 billion rupees ($197.33 million) for the fiscal year ended March 31. The company is focusing on partnerships with global capability centers, hubs that manage operations, finance, and research for large multinational firms, to drive growth, Narang added. Apple, which reported nearly $8 billion in sales in India for the year through March 2024, operates its own stores in New Delhi and Mumbai. Other resellers in the market include Aptronix and iPlanet.
While Apple also plans to expand its presence in India, Narang said that would benefit partners like Ample, as the market tends to grow with the brand's presence.
The firm plans to list on stock exchanges within five years to fund its growth strategy. "With our growth ambition, there will be a need for capital," Narang said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Ashish Kacholia invested in this SME IPO that has 42% GMP. Check all details
Ashish Kacholia invested in this SME IPO that has 42% GMP. Check all details

Time of India

time20 minutes ago

  • Time of India

Ashish Kacholia invested in this SME IPO that has 42% GMP. Check all details

Patel Chem Specialities is set to launch its Rs 58.80 crore IPO today, with the price fixed at Rs 82–84 per share. Ahmedabad-based Patel Chem Specialities launched its Rs 58.80 crore IPO today, priced at Rs 82–84 per share. The IPO, entirely a fresh issue, closes on July 29 and plans to list on BSE SME on August 1. Ashish Kacholia, along with other investors, participated in the anchor book, raising Rs 16.69 crore. Tired of too many ads? Remove Ads Price band and GMP Tired of too many ads? Remove Ads Company overview Ahmedabad-based excipient maker Patel Chem Specialities will launch its Rs 58.80 crore IPO today at a price band of Rs 82–84 per share. The offer is entirely a fresh issue of 70 lakh equity shares and will close for subscription on July 29. The company will list on the BSE SME platform, with a tentative listing date of August IPO has drawn early attention after ace investor Ashish Kacholia , via Bengal Finance and Investment, was allotted 5.97 lakh shares as part of the anchor book at Rs 84 per share -- accounting for nearly one-third of the anchor notable investors include Meru Investment Fund, Zeal Global Opportunities Fund, and Ventura Fund I. In total, Rs 16.69 crore was raised from anchor issue is priced at Rs 82–84 per share with a lot size of 1,600 shares. The grey market premium (GMP) is hovering at around 42% over the issue price, indicating strong interest ahead of Chem is a manufacturer of pharmaceutical excipients and specialty chemicals like sodium carboxymethyl cellulose and pregelatinized operates from two plants in Gujarat and exports to over five continents. For FY25, it posted a 28% revenue growth to Rs 105.5 crore, while PAT jumped 38% to Rs 10.57 proceeds from the IPO will be used for funding capital expenditure requirement of the company and other general corporate purposes.

Buy or sell: Vaishali Parekh recommends three stocks to buy today — 25 July 2025
Buy or sell: Vaishali Parekh recommends three stocks to buy today — 25 July 2025

Mint

time20 minutes ago

  • Mint

Buy or sell: Vaishali Parekh recommends three stocks to buy today — 25 July 2025

Buy or sell stocks: The benchmark indices of the Indian stock market began the session on a weak footing and remained under pressure throughout the weekly expiry, as lacklustre Q1 results 2025 from IT majors triggered a sharp sell-off in the sector, weighing on overall sentiment. Caution also prevailed before next week's U.S. Federal Reserve policy decision, likely to steer global market direction. The Sensex dropped 542.47 points, or 0.66%, to close at 82,184.17, while the Nifty fell 157.80 points, or 0.63%, settling at 25,062.10. Sector-wise, PSU Banks, Healthcare, and Pharma outperformed in positive territory, bucking the broader downtrend. In contrast, heavy selling was seen across most other sectors, with the IT index sliding over 2%, leading the losses. Broader markets also came under selling pressure, with the Nifty Midcap index down 0.58% and the Small-cap index shedding 1.09%, indicating a weak undertone across segments. Vaishali Parekh, Vice President of Technical Research at Prabhudas Lilladher, believes the Indian stock market sentiment is sideways to positive. The Nifty 50 index is sustaining above the 50-DEMA support of 24,900, while the key benchmark index faces resistance at 25,250. Speaking on the outlook of the Nifty 50 today, Vaishali Parekh said, "The Nifty 50 index once again found resistance near the hurdle of 25,250 zone and witnessed profit booking to slip towards the 25,000 zone to indicate a tight rangebound movement between 25,000 and 25,250 level for quite some time, with overall bias maintained positive. As mentioned earlier, we continue to maintain our stance, would need a decisive breach above the 25,250 to 25,300 zone to continue with the positive movement further ahead and expect the next targets of 25,500 and 25,700 levels in the coming days, provided the crucial support zone of 24,900 level is sustained as of now." "The Bank Nifty index continues to move within a tight range, having the tough resistance barrier near the 57,300 zone, which needs to be breached decisively and expect further upward movement in the coming days. On the downside, the 50-DEMA zone at the 56,000 level shall be an important and crucial support which needs to be sustained to maintain the overall bias and sentiment intact," said Parekh. Parekh said that the immediate support for the Nifty 50 index is at 24,900, while the resistance is at 25,300. The Bank Nifty would have a daily range of 56,500 to 57,600. Regarding stocks to buy today, Vaishali Parekh recommended three buy-or-sell stocks: Bandhan Bank, REC, and Hubtown. 1] Bandhan Bank: Buy at ₹ 184, Target ₹ 190, Stop Loss ₹ 180; 2] REC: Buy at ₹ 405.50, Target ₹ 412, Stop Loss ₹ 398; and 3] Hubtown: Buy at ₹ 305, Target ₹ 325, Stop Loss ₹ 295. Disclaimer: The views and recommendations made above are those of individual analysts or brokerage companies and not of Mint. We advise investors to check with certified experts before making any investment decisions.

Ashish Kacholia invested in this SME IPO that has 42% GMP. Check all details
Ashish Kacholia invested in this SME IPO that has 42% GMP. Check all details

Economic Times

time20 minutes ago

  • Economic Times

Ashish Kacholia invested in this SME IPO that has 42% GMP. Check all details

Ahmedabad-based excipient maker Patel Chem Specialities will launch its Rs 58.80 crore IPO today at a price band of Rs 82–84 per share. The offer is entirely a fresh issue of 70 lakh equity shares and will close for subscription on July 29. The company will list on the BSE SME platform, with a tentative listing date of August 1. ADVERTISEMENT The IPO has drawn early attention after ace investor Ashish Kacholia, via Bengal Finance and Investment, was allotted 5.97 lakh shares as part of the anchor book at Rs 84 per share -- accounting for nearly one-third of the anchor portion. Other notable investors include Meru Investment Fund, Zeal Global Opportunities Fund, and Ventura Fund I. In total, Rs 16.69 crore was raised from anchor investors. The issue is priced at Rs 82–84 per share with a lot size of 1,600 shares. The grey market premium (GMP) is hovering at around 42% over the issue price, indicating strong interest ahead of Chem is a manufacturer of pharmaceutical excipients and specialty chemicals like sodium carboxymethyl cellulose and pregelatinized starch. ADVERTISEMENT It operates from two plants in Gujarat and exports to over five continents. For FY25, it posted a 28% revenue growth to Rs 105.5 crore, while PAT jumped 38% to Rs 10.57 proceeds from the IPO will be used for funding capital expenditure requirement of the company and other general corporate purposes. ADVERTISEMENT (You can now subscribe to our ETMarkets WhatsApp channel)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store